December 14, 2006 – At one point in our illustrious history, the US famously needed a good nickel cigar. Now it needs less expensive healthcare. Bridge Pharmaceuticals has moved to fill that latter need. Bridge was formed in 2004 as a spin-out from Menlo Park-based SRI International (which was once known as Stanford Research Institute). It has opened an animal testing lab in Beijing that aims to lower the costs of drug development. More details...
